Oracle Alpha Inc. Ptc Therapeutics, Inc. Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
A detailed history of Oracle Alpha Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 18,755 shares of PTCT stock, worth $970,196. This represents 0.98% of its overall portfolio holdings.
Number of Shares
18,755
Previous 12,209
53.62%
Holding current value
$970,196
Previous $336 Million
62.14%
% of portfolio
0.98%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
284Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$445 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$402 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$387 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$281 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$280 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.7B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...